Comportamientos relacionados con la salud y apoyo familiar y síntomas clínicos de HPB: Un estudio piloto de China
28-04-2017
Este estudio pretende explorar el efecto de comportamientos relacionados con la salud en los síntomas clínicos de pacientes con hiperplasia prostática benigna (HPB), así como proveer algunas pistas para el control de estos. Los investigadores obtuvieron información, entre junio y septiembre de 2011, de tres hospitales en China sobre los comportamientos de los pacientes relacionados con la salud, como la ingesta de café (entre otros). La muestra se compuso de todos los hombres con HPB que visitaron el departamento de urología de los tres centros del estudio; de los 231 pacientes de la población blanco, solo 6 se negaron a completar la encuesta. Después de realizar las pruebas estadísticas pertinentes, solo el consumo regular de esta sustancia (OR = 0.33, 95% CI: 0.11–0.96) y tomar agua constantemente (OR = 0.44, 95% CI: 0.24–0.81) tuvieron efectos significativos en el IPSS (International Prostatic Symptom Score). A pesar de algunas limitaciones, el estudio provee una evidencia preliminar sobre el rol del café los hombres con HPB.
Referencias
Barry MJ, Fowler FJ, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. (1992). The American Urological Association symptom index for benign prostatic hyperplasia.
The Measurement Committee of the American Urological Association. The Journal of Urology; 148 (5):1549–1557, 1564.
Borrell-Carrio F, Suchman AL, Epstein RM. (2004). The biopsychosocial model 25 years later: principles, practice, and scientific inquiry. The Annals of Family Medicine; 2 (6): 576–582.
Bravi F, Bosetti C, Dal Maso L, Talamini R, Montella M, Negri E, Ramazzotti V, Franceschi S, La Vecchia C. (2006). Food groups and risk of benign prostatic hyperplasia. Urology; 67 (1): 73–79.
Cheng ST, Chan AC. (2006). Filial piety and psychological wellbeing in well older Chinese. The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences; 61 (5):262–269.
Chou RJ. (2011). Perceived need and actual usage of the family support agreement in rural China: results from a nationally representative survey.
Gerontologist; 51 (3):295–309. Dowrick C, May C, Richardson M, Bundred P. (1996). The biopsychosocial model of general practice: rhetoric or reality? British Journal of General Practice; 46 (403):105–107.
Engel GL. (1977). The need for a new medical model: a challenge for biomedicine. Science; 196 (4286):129–136.
Fukuta F, Masumori N, Mori M, Tsukamoto T. (2012). Natural history of lower urinary tract symptoms in Japanese men from a 15-year longitudinal community-based study. BJU International.
Gass R. (2002). Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake. BJU International; 90 (7): 649–654.
Gatchel RJ, Turk DC. (2008). Criticisms of the biopsychosocial model in spine care: creating and then attacking a straw person. Spine (Phila Pa 1976); 33 (25):2831–2836.
Gotoh M, Ono Y, Ohshima S. (2002). Clinical guideline for benign prostatic hyperplasia. Nihon Rinsho; 60 (Suppl. 11):311–317.
Hammad FT,Kaya MA. (2010).Development and validation of an Arabic version of the International Prostate Symptom Score. BJU International; 105 (10):1434–1438.
Higdon JV, Frei B. (2006). Coffee and health: a review of recent human research. Critical Reviews in Food Science and Nutrition; 46 (2):101–123.
Joseph MA, Harlow SD, Wei JT, Sarma AV, Dunn RL, Taylor JM, James SA, Cooney KA, Doerr KM, Montie JE, Schottenfeld D. (2003). Risk factors for lower urinary tract symptoms in a population-based sample of African-Americanmen. American Journal of Epidemiology; 157 (10):906–914.
Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, AntvelinkCM, Penson DF, Thompson IM. (2007).
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. The Journal of Urology; 177 (4): 1395–1400, 1591.
Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO, Trichopoulos D. (1999). Diet and benign prostatic hyperplasia: a study in Greece. Urology; 54 (2):284–290.
Lee EH, Chun KH, Lee Y. (2005). Benign prostatic hyperplasia in community-dwelling elderly in Korea. Journal of Korea Academy of Nursing; 35 (8):1508–1513.
Li Y, Chi I. (2011). Correlates of physician visits among older adults in China: the effects of family support. Journal of Aging and Health; 23 (6):933–953.
McClure MW. (2002). An overview of holistic medicine and complementary and alternative medicine for the prevention and treatment of BPH, prostatitis, and prostate cancer. World Journal of Urology; 20 (5): 273–284.
Morrison AS. (1992). Risk factors for surgery for prostatic hypertrophy. American Journal of Epidemiology; 135 (9): 974–980.
Parsons JK. (2010). Benign Prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors.
Current Bladder Dysfunction Reports; 5 (4):212–218. Ning X, Shi JP, Wu ZY, Zheng LG, Wang HL. (2003). A casecontrol study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang. Chinese Journal of Epidemiology; 24 (4):276–280.
Platz EA, Rimm EB, Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Giovannucci E. (1999). Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia. American Journal of Epidemiology; 149 (2):106–115.
Prezioso D, Catuogno C, Galassi P, D’Andrea G, Castello G, Pirritano D. (2001). Life-style in patients with LUTS suggestive of BPH. European Urology; 40 (Suppl. 1):9–12.
Roberts RO, Tsukamoto T, Kumamoto Y, Rhodes T, Masumori N, Miyake H, Girman CJ, Jacobsen SJ, Lieber MM. (1997).
Association between cigarette smoking and prostatism in a Japanese community. Prostate; 30 (3):154–159. de la Rosette JJ, Alivizatos G, Madersbacher S, Perachino M,
Thomas D, Desgrandchamps F, de Wildt M. (2001). EAU Guidelines on benign prostatic hyperplasia (BPH). European Urology; 40 (3):256–263, 264.
Rosland AM, Piette JD. (2010). Emerging models for mobilizing family support for chronic disease management: a structured review. Chronic Illness; 6 (1):7–21.
Santos MA, Alves RC, Oliveira VA, Ribas CR, Teixeira CR, Zanetti ML. (2011). Social representations of people with diabetes regarding their perception of family support for the treatment. Revista da Escola de Enfermagem da USP; 45 (3):651–658.
Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, ArtibaniW, Begaud B, BergesR, Borkowski A, Chappel CR, Costello A, Dobronski P, Farmer RD, Jimenez CF, Jonas U, MacRae K, Pientka L, Rutten FF, van Schayck CP, Speakman MJ, Sturkenboom MC, Tiellac P, Tubaro A, Vallencien G, Vela NR. (2002). Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care – the Triumph project. European Urology; 42 (4):323–328.
Wu ZD, Wu ZH. (2011).Surgery, 7th edn. Beijing, China: People’s Medical Publishing House. Yuan SC, Weng SC, Chou MC, Tang YJ, Lee SH, Chen DY, Chuang YW, Yu CH, Kuo HW. (2011). How family support affects physical activity (PA) among middle-aged and elderly people before and after they suffer from chronic diseases.
Archives of Gerontology and Geriatrics; 53 (3):274–277.
